Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.780
-0.010 (-0.56%)
At close: Dec 5, 2025, 4:00 PM EST
1.780
0.00 (-0.02%)
After-hours: Dec 5, 2025, 7:07 PM EST
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $66.83 million as of December 5, 2025. Its market cap has increased by 2.05% in one year.
Market Cap
66.83M
Enterprise Value
-75.24M
1-Year Change
2.05%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $66.83M, a decrease of -88.13%. That is a compound annual growth rate of -69.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 67.21M | -50.25% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |